20 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
10 May 18
Bio-Path Holdings Appoints Dr. Anas Younes to Scientific Advisory Board
5:02pm
of Medicine. He completed his internal medicine residency training at SUNY Downstate Medical Center and his pathology residency at the Medical College of Ohio … . He completed his hematology fellowship training at MSK.
About Bio-Path Holdings, Inc.
Bio-Path is a biotechnology company developing DNAbilize®
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
26 Mar 14
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
12:00am
-University of Washington comprehensive cancer consortium including compliance, clinical staff training, regulatory affairs, protocol development
424B3
xu0 c3hwk8558j1l
30 Mar 12
Prospectus supplement
12:00am
424B3
lsvuh 2bxklbxtlpnxmr
1 Apr 11
Prospectus supplement
12:00am
424B3
t1gpiv8 4lcawga
29 Jul 10
Prospectus supplement
12:00am
S-1
m3v5t2vjzp l7kf
17 Jun 10
IPO registration
12:00am
DEF 14A
fov5l890qenicx c7sa
29 May 09
Definitive proxy
12:00am
10-K
qwd7r30
3 Apr 09
Annual report
12:00am
8-K
25gejnu5lqgwrd
19 Feb 08
Completion of Acquisition or Disposition of Assets
12:00am
SB-2/A
ekqy30yklxno1t
6 Aug 03
Registration of securities for small business issuer (amended)
12:00am
SB-2
14ng3oq5x2e376d0 dv9
8 May 03
Registration of securities for small business issuer
12:00am
SB-2
EX-1
essmn
8 May 03
Registration of securities for small business issuer
12:00am
- Prev
- 1
- Next